Marjoram oil attenuates oxidative stress and improves colonic epithelial barrier function in dextran sulfate sodium-induced ulcerative colitis in Balb/c mice
Main Article Content
Keywords
dextran sulfate sodium, experimental colitis, Origanum majorana, oxidative stress, inflammation, Ussing chamber
Abstract
In this study, we explored the effects of marjoram oil (MO) on dextran sulfate sodium (DSS)-induced colitis in Balb/c mice. Marjoram oil was found to significantly reduce the severity of DSS-induced colonic inflammation, as reflected by improved disease activity index, prevented colon length shortening, lower histopathological score, decreased myeloperoxidase activity, and reduced interlukin 6 (IL-6) levels. Moreover, marjoram oil pretreatment enhanced the colonic epithelial integrity by decreasing paracellular permeability. Marjoram oil was found to clearly reduce the colonic levels of thiobarbituric acid reactive substances assay and enhance the activity of superoxide dismutase, catalase, and glutathione sulfhydryl content. Marjoram oil could exert a protective effect on ulcerative colitis through its anti-inflammatory and antioxidant properties.
References
Al Dhaheri, Y., Attoub, S., Arafat, K., Abuqamar, S., Viallet, J., Saleh, A., Al Agha, H., Eid, A. and Iratni, R. 2013. Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: Inhibition of NF_B signaling and reduction of nitric oxide production. PLoS One 8(7):e68808. 10.1371/journal.pone.0068808
Al-Howiriny, T., Alsheikh, A., Alqasoumi, S., Al-Yahya, M., El Tahir, K. and Rafatullah, S. 2009. Protective effect of Origanum majorana L. “marjoram” on various models of gastric mucosal injury in rats. Am. J. Chin. Med. 37(3):531–545. 10.1142/s0192415x0900703x
Amirshahrokhi, K., Bohlooli, S. and Chinifroush, M.M. 2011. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicol Appl Pharmacol. 253(3):197–202. 10.1016/j.taap.2011.03.017
Arranz, E., Jaime, L., López de las Hazas, M.C., Reglero, G. and Santoyo, S. 2015. Supercritical fluid extraction as an alternative process to obtain essential oils with anti-inflammatory properties from marjoram and sweet basil. Indu Crops Prod. 67:121–129. 10.1016/j.indcrop.2015.01.012
Athamneh, K., Alneyadi, A., Alsamri, H., Alrashedi, A., Palakott, A., El-Tarabily, K.A., Eid, A.H., Al Dhaheri, Y. and Iratni, R. 2020. Origanum majorana essential oil triggers p38 MAPK-mediated protective autophagy, apoptosis, and caspase-dependent cleavage of P70S6K in colorectal cancer cells. Biomolecules. 10(3):412. 10.3390/biom10030412
Baakhtari, S., McCombie, A., BokkelHuinink, S., Irving, P., Siegel, C.A., Mulde, R., Mulder, C.J. and Gearry, R. 2018. Observational study of perspectives of inflammatory bowel disease patients concerning the use of corticosteroids. Dig Dis (Basel). 36(1):33–39. 10.1159/000478772
Bang, B. and Lichtenberger, L.M. 2016. Methods of inducing inflammatory bowel disease in mice. Curr Protoc Pharmacol. 72(5):1–42. 10.1002/0471141755.ph0558s72
Benhalilou, N., Alsamri, H., Alneyadi, A., Athamneh, K., Alrashedi, A., Altamimi, N., Al Dhaheri, Y., Eid, A.H. and Iratni, R., 2019. Origanum majorana ethanolic extract promotes colorectal cancer cell death by triggering abortive autophagy and activation of the extrinsic apoptotic pathway. Front Oncol. 9:795. 10.3389/fonc.2019.00795
Bhattacharyya, A., Chattopadhyay, R., Mitra, S. and Crowe, S.E. 2014. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 94(2):329–354. 10.1152/physrev.00040.2012
Bouayad Debbagh, I., Grar, H., Saidi, D., Kheroua, O. and Kaddouri, H. 2021. Phytochemical analysis and in vitro antioxidant activities of marjoram oil. Biosci Res. 18(4):2888–2894.
Catanzaro, D., Rancan, S., Orso, G., Dall’Acqua, S., Brun, P., Giron, M.C., Carrara, M., Castagliulo, I., Ragazzi, E., Caparrotta, L. and Montopoli, M. 2015. Boswellia serrata preserves intestinal epithelial barrier from oxidative and inflammatory damage. PLoS One. 10(5):e0125375. 10.1371/Fjournal.pone.0125375
Cheifetz, AS., Gianoti, R., Luber, R and Gibson, P.R. 2017. Complementary and alternative medicines used by patients with inflammatory bowel diseases. Gastroenterology. 152(2):415–429. 10.1053/j.gastro.2016.10.004
Cooper, H.S., Murthy, S.N., Shah, R.S. and Sedergran, D.J. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 69(2):238–249. PMid: 8350599.
Della Pepa, T., Elshafie, H.S., Capasso, R., DeFeo, V., Camele, I., Nazzaro, F., Scognamiglio, M.R. and Caputo, L. 2019. Antimicrobial and phytotoxic activity of Origanum heracleoticum and O. majorana essential oils growing in Cilento (Southern Italy). Molecules. 24(14):2576. 10.3390/molecules24142576
Duletic, S., Alimpi´cAradski, A., Kolarevic, S., Vuković-Gačić, B., Oaldje, M., Živkovi´c, J., Šavikin, K. and Marin, P. 2018. Antineurodegenerative, antioxidant and antibacterial activities and phenolic components of Origanum majorana L. (Lamiaceae) extracts. J Appl Bot Food Qual. 91:126–134. 10.5073/JABFQ.2018.091.018
Erenler, R., Sen, O., Aksit, H., Demirtas, I., Yaglioglu, A.S., Elmastas, M. and Telci, I. 2016. Isolation and identification of chemical constituents from Origanum majorana and investigation of antiproliferative and antioxidant activities. J Sci Food Agric. 96(3):822–836. 10.1002/jsfa.7155
Guerra-Boone, L., Alvarez-Roman, R. and Salazar-Aranda, R. 2015. Antimicrobial and antioxidant activities and chemical characterization of essential oils of Thymus vulgaris, Rosmarinus officinalis, and Origanum majorana from northeastern Mexico. Pak J Pharm Sci. 28(1):363–369. PMid: 2563151421.
Goel, P. and Vasudeva, N. 2015. Origanum majorana L.–phyto-pharmacological review. Indian J Nat Prod Res. 6:261–267. https://op.niscpr.res.in/index.php/IJNPR/article/view/6800/590
Goyal, N., Rana, A., Ahlawat, A., Bijjem, K.R.V. and Kumar, P. 2014. Animal models of inflammatory bowel disease. Rev Inflammopharmacol. 22(4):219–233. 10.1007/s10787-014-0207-y
Helieh, O., Cheresa, T., Willem, J.S. and Villiers, D. 2013. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front Immunol. 5(4):132. 10.3389/fimmu.2013.00132
Iba, Y., Sugimoto, Y., Kamei, C. and Masukawa, T. 2003. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats. Int Immunopharmacol. 3(4):485–491. 10.1016/s1567–5769(02)00299-0
Kitajima, S., Takuma, S. and Morimoto, M. 1999. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 48(3):137–143. 10.1538/expanim.48.137
Klebanoff, S.J. 2005. Myeloperoxidase: friend and foe. J Leukoc Bio. 77(5):598–625. 10.1189/jlb.1204697
Kokkinidis, D.G., Bosdelekidou, E.E. and Iliopoulou, S.M. 2017. Emerging treatments for ulcerative colitis: a systematic review. Scand J Gastroenterol. 52(9):923–931. 10.1080/00365521.2017.1326163
Landy, J., Ronde, E., English, N., Clark, S.K., Hart, A.L., Knight, S., Ciclitira, P. J. and Al-Hassi, H.O. 2016. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J. Gastroenterol. 22(11):3117–3126. 10.3748/wjg.v22.i11.3117
Larussa, T., Imeneo, M. and Luzza, F. 2017. Potential role of nutraceutical compounds in inflammatory bowel disease. World J. Gastroenterol. 23(14):2483–2492. 10.3748/wjg.v23.i14.2483
Lenoir, L., Rossary, A., Joubert-Zakeyh, J., Vergnaud-Gauduchon, J., Farges, M-C., Fraisse, D., Texier, O., Lamaison, J.L., Vasson, M.P. and Felgines, C. 2011. Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat. Dig Dis Sci. 56(12):3534–3545. 10.1007/s10620-011-1784-x
Lewellyn, S.R., Britton, G.J., Contijoch, E.J., Mortha, A.J.F., Colombel, J.F.A., Grinspan, A., Clemente, J.C., Merad, M. and Faith, J.J. 2017. Deciphering the combinatorial influence of diet and the microbiota on experimental colitis. BioRxiv. 117929. Epub ahead of print. 10.1101/117929
Lin, SC. and Cheifetz, A.S. 2018. The use of complementary and alternative medicine in patients with inflammatory bowel disease. Gastroenterol Hepatol. 14(7):415–425. PMid: 30166957.
Liu, Y., Wang, X., Hou, Y., Yin, Y., Qiu, Y., Wu, G. and Hu, C.A.A. 2017. Roles of amino acids in preventing and treating intestinal diseases: recent studies with pig models. Amino Acids. 49(8):1277–1291. 10.1007/s00726-017-2450-1
Lowry, O.H., Rose Rough, NJ., Farr, AL. and Randall, RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem. 193(1):265–275. 10.1016/S0021-9258(19)52451-6
Makrane, H., Aziz, M., Mekhfi, H., Ziyyat, A., Legssyer, A. and Melhaoui, A. 2018. Origanum majorana L. extract exhibit positive cooperative effects on the main mechanisms involved in acute infectious diarrhoea. J Ethnopharmacol. 239:111503. 10.1016/j.jep.2018.09.005
Maloy, K.J. and Powrie, F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 474(7351):298–306. 10.1038/nature10208
Malle, E., Furtmüller, P.G., Sattler, W. and Obinger, C. 2007. Myeloperoxidase: a target for new drug development? Br J Pharmacol. 152(6):838–854. 10.1038/Fsj.bjp.0707358
Mandalari, G., Bisignano, C., Genovese, T., Mazzon, E., Wickham, M.S. and Paterniti, I. 2011. Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease. Int Immunopharmacol. 11(8):915–24. 10.1016/j.intimp.2011.02.003
Marklund, S.L. and Marklund, G. 1974. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47(3):469–474. 10.1111/j.1432-1033.1974.tb03714.x
Mazur-Bialy, A.I., Bilski, J., Wojcik, D., Brzozowski, B., Surmiak, M., Hubalewska Mazgaj, M., Chmura, A., Magierowski, M., Magierowska, K. and Mach, T. 2017. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of irisin, adiponectin and proinflammatory biomarkers. Nutrients. 9(4):410. 10.3390/nu9040410
Mekkioui, A. and Djerdjouri, B. 2012. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol. 691(1–3):209–217. 10.1016/j.ejphar.2012.06.014
Mijan, A.L. and Lim, B.O. 2018. Diets. Functional foods and nutraceuticals as alternative therapies for inflammatory bowel disease: present status and future trends. World J Gastroenterol. 24(25):2673–2685. 10.3748/Fwjg.v24.i25.2673
Młodzik-Danielewicz, N. and Tyrakowski, T. 2005. Effects of amiloride and bumetanide on hyperpolarization after movement across the distal colon epithelium. Pharmacol Rep. 57(4):489–497. PMid: 16129916.
Mossa, A.T., Refaie, A.A., Ramadan, A. and Bouajila, J. 2013. Amelioration of prallethrin-induced oxidative stress and hepatotoxicity in rat by the administration of Origanum majorana essential oil. Biomed Res Int. 2013:859085. 10.1155/2013/859085
Mueller, K., Blum, N.M. and Mueller, A.S. 2013. Examination of the anti-inflammatory, antioxidant, and xenobiotic-inducing potential of broccoli extract and various essential oils during a Mild DSS-induced colitis in rats. ISRN Gastroenterol. 2013:710856. 10.1155/2013/710856
Nishiyama, Y., Kataoka, T., Yamato, K., Taguchi, T. and Yamaoka, K. 2012. Suppression of dextran sulfate sodium-induced colitis in mice by radon inhalation. Mediators Inflamm. 2012:239617. 10.1155/2012/239617
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98(3):694–702. 10.1016/0016-5085(90)90290-h
Oz, H.S., Chen, T.S., McClain, C.J. and de Villiers, W.J.S. 2005. Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem. 16(5):297–304. 10.1016/j.jnutbio.2004.09.007
Pandurangan, A.K., Mohebali, N., Norhaizan, M.E. and Looi, C.Y. 2015. Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des Devel Ther. 9:3923–3934. 10.2147/FDDDT.S86345
Paterson, J.R., Srivastava, R., Baxter, G.J., Graham, A.B. and Lawrence, J.R. 2006. Salicylic acid content of spices and its implications. J Agric Food Chem. 54(8):2891–2896. 10.1021/jf058158w
Perse, M. and Cerar, A. 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. Biomed Biotechnol. 2012:718617. 10.1155/2012/718617
Ramadan, G., El-Beih, N.M., Arafa, NM. and Zahra, M.M. 2013. Preventive effects of Egyptian sweet marjoram (Origanum majorana L.) leaves on hematological changes and cardiotoxicity in isoproterenol-treated albino rats. Cardiovasc Toxicol. 13(2):100–109. 10.1007/s12012-012-9189-4
Rodrigues, M.R.A., Caram̃ao, E.B., Arce, L., R´ıos, A. and Valc´arcel, M. 2002. Determination of monoterpene hydrocarbons and alcohols in Majorana shortness Moench by micellar electro kinetic capillary chromatographic. J Agric Food Chem. 50(15):4215–4220. 10.1021/jf011667n
Salih, A.M., Smith, D.M., Price, J.F. and Dawson, L.E. 1987. Modifid extraction 2 thiobarbituric acid method for measuring lipid oxidation in pountry. Poultry Sci. 66(9):1483–1488. 10.3382/ps.0661483
Sedlak, J. and Lindsay, R.H. 1968. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 25(1):192–205. 10.1016/0003-2697(68)90092-4
Stillie, R. and Stadnyk, A.W. 2009. Role of TNF receptors, TNFR1 and TNFR2 in dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 15(10):1515–1525. 10.1002/ibd.20951
Su, L., Nalle, S.C., Shen, L., Turner, E.S., Singh, G., Breskin, L.A., Khramtsova, E.A., Khramtsova, G., Tsai, P.Y., Fu, Y.X.C., Abraham, C.J.R. and Turner, J.R. 2013. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology. 145(2):407–415. 10.1053/j.gastro.2013.04.011
Tahan, G., Aytac, E., Aytekin, H., Gunduz, F., Dogusoy, G., Aydin, S., Tahan, V. and Uzun, H. 2011. Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg. 54(5):333–338. 10.1503/cjs.013610
Trouillas, P., Calliste, C.A., Allais, DP., Simon, A., Ma, A., Delage, C. and Duroux, J.L. 2003. Antioxidant, anti-inflammatory and antioxidant antiproliferative properties of sixteen water plant extracts used in the Limousin countryside as herbal teas. Food Chem. 80(3):399–407. 10.1016/S0308-8146(02)00282-0
Uko, V., Thangada, S. and Radhakrishnan, K. 2012. Liver disorders in inflammatory bowel disease. Gastroenterol Res Pract. 2012:642923. 10.1155/2012/642923
Valatas, V., Vakas, M. and Kolios, G. 2013. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am. J. Physiol. Gastrointest. Liver Physiol. 305(11):763–785. 10.1152/ajpgi.00004.2013
Wan, P., Chen, H., Guo, Y. and Bai, A.P. 2014. Advances in treatment of ulcerative colitis with herbs: from bench to bedside. World J Gastroenterol. 20(39):14099–14104. 10.3748/wjg.v20.i39.14099
Wang, Z., Adachi, S., Kong, L., Watanabe, D., Nakanishi, Y., Ohteki, T., Hoshi, N. and Kodama, Y. 2019. Role of eosinophils in a murine model of inflammatory bowel disease. Biochem Biophys Res Commun. 511(1):99–104. 10.1016/j.bbrc.2019.02.056
Wardman, P. 2007. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biomed. 43(7):995–1022. 10.1016/j.freeradbiomed.2007.06.026
Xing, J., You, C., Dong, K., Sun, J., You, H. and Dong, Y. 2013. Ameliorative effects of 3,4-oxo isopropylideneshikimic acid on experimental colitis and their mechanisms in rats. Int Immunopharmacol. 15(3):524–31. 10.1016/j.intimp.2013.02.008
Xu, L., Yang, Z.L., Li, P. and Zhou, Y.Q. 2009. Modulating effect of hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine. 16(10):989–995. 10.1016/j.phymed.2009.02.021
Yan, H., Wang, H., Zhang, X., Li, X. and Y.J. 2015. Ascorbic acid ameliorates oxidative stress and inflammation in dextran sulfate sodium induced ulcerative colitis in mice. Int J Clin Exp Med. 8(11):20245–20253. https://www.ncbi.nlm.nih.gov/pubmed/26884937
Yang, B.L., Chen, Y.G. and Gu, Y.F. 2015. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn’s disease. World J Gastroenterol. 21(8):2475–2482. 10.3748/Fwjg.v21.i8.2475
Zhu, H. and Li, Y.R. 2012. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood). 237(5):474–480. 10.1258/ebm.2011.011358